Rob Warnock
YOU?
Author Swipe
View article: Patient characteristics of Medicare beneficiaries who report not getting influenza and pneumococcal vaccinations, 2001–2013
Patient characteristics of Medicare beneficiaries who report not getting influenza and pneumococcal vaccinations, 2001–2013 Open
Background: Despite long standing recommendations of pneumococcal and influenza vaccination for adults age 65 years and older and wide-spread availability to vaccination services, vaccination coverage in the United states is low. We sought…
View article: 151. Evaluation of Pneumococcal Vaccine Effectiveness Against Invasive Pneumococcal Disease Among US Medicare Beneficiaries ≥65 Years Old
151. Evaluation of Pneumococcal Vaccine Effectiveness Against Invasive Pneumococcal Disease Among US Medicare Beneficiaries ≥65 Years Old Open
Background Pneumococcal conjugate vaccine (PCV13) was recommended in series with PPSV23 for all US adults ≥65 years in late 2014. We evaluated effectiveness of PCV13 against invasive pneumococcal disease (IPD) among Medicare beneficiaries …
View article: Influenza vaccination coverage estimates in the fee-for service Medicare beneficiary population 2006 – 2016: Using population-based administrative data to support a geographic based near real-time tool
Influenza vaccination coverage estimates in the fee-for service Medicare beneficiary population 2006 – 2016: Using population-based administrative data to support a geographic based near real-time tool Open
Older adults are at great risk of developing serious complications from seasonal influenza. We explore vaccination coverage estimates in the Medicare population through the use of administrative claims data and describe a tool designed to …
View article: Pediatric Use of Antipsychotic Medications Before and After Medicaid Peer Review Implementation
Pediatric Use of Antipsychotic Medications Before and After Medicaid Peer Review Implementation Open
This population-based study examines the changes in use of atypical antipsychotic medication in young children with peer review prior authorization policies.
View article: Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years
Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years Open
On September 19, 2014, CDC published the Advisory Committee on Immunization Practices (ACIP) recommendation for the routine use of 13-valent pneumococcal conjugate vaccine (PCV13) among adults aged ≥65 years, to be used in series with 23-v…
View article: Babesiosis Occurrence among the Elderly in the United States, as Recorded in Large Medicare Databases during 2006–2013
Babesiosis Occurrence among the Elderly in the United States, as Recorded in Large Medicare Databases during 2006–2013 Open
Our study reveals increasing babesiosis occurrence among the U.S. elderly during 2006-2013, with highest rates in the babesiosis-endemic states. The study also shows variation in babesiosis occurrence by age, gender, race, state of residen…